Marc P. Bonaca, MD, MPH

Marc P. Bonaca, MD, MPH, is the executive director of CPC Clinical Research, the director of Vascular Research, a professor in the Division of Cardiology at the University of Colorado School of Medicine, and William R. Hiatt Endowed Chair in Cardiovascular Research.

Articles by Marc P. Bonaca, MD, MPH

Closing the uACR Gap in CRM Care: Marc P. Bonaca, MD, MPH, and Josephine Harrington, MD

ByBrooke McCormick,Josephine Harrington, MD ,Marc P. Bonaca, MD, MPH

April 30th 2026

Marc P. Bonaca, MD, MPH, and Josephine Harrington, MD, discuss the clinical value of the uACR test and why it remains underutilized.

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

ByMario Enrico Canonico, MD, PhD,Judith Hsia, MD,Shih-Ting Chiu, PhD,Pu-Kai Tseng,James O. Mudd, MD,Joshua D. Remick, MD,Bansi Patel, MS,Ya-Hsiu Chuang, PhD,Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC,Marc P. Bonaca, MD, MPH

August 14th 2025

The analysis highlighted a shift in heart failure diagnoses, with hypertensive heart disease with and without chronic kidney disease as prevalent diagnoses, underlining coding variability and implications for research.

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

ByGiuliana Grossi,Christian Ruff, MD,John Buse, MD, PhD,Marc P. Bonaca, MD, MPH,Marc Humbert, MD, PhD,Jawad Haider Butt, MD, PhD,Siddharth M. Patel, MD, MPH

April 4th 2025

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.

Semaglutide Demonstrates Enhanced Walking Capacity in ACC.25 STRIDE Data

ByGiuliana Grossi,Marc P. Bonaca, MD, MPH

March 30th 2025

STRIDE investigator Marc Bonaca, MD, MPH, University of Colorado School of Medicine, highlights how the data could provide insight into peripheral artery disease and type 2 diabetes treatment options.

Latest Updated Articles

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems
August 14th 2025
Closing the uACR Gap in CRM Care: Marc P. Bonaca, MD, MPH, and Josephine Harrington, MD
April 30th 2026
Semaglutide Demonstrates Enhanced Walking Capacity in ACC.25 STRIDE Data
March 30th 2025

Marc P. Bonaca, MD, MPH

Articles by Marc P. Bonaca, MD, MPH

Closing the uACR Gap in CRM Care: Marc P. Bonaca, MD, MPH, and Josephine Harrington, MD

Temporal Shift in Prevalence of Heart Failure Diagnoses and Comorbidities Within 2 US Integrated Health Systems

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

Semaglutide Demonstrates Enhanced Walking Capacity in ACC.25 STRIDE Data

Latest Updated Articles

Trending on AJMC

EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Teclistamab Outperforms Len/Dex in High-Risk Smoldering Myeloma With Higher CR Rate, PFS: Omar Nadeem, MD

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

SENTRY Trial Shows Survival, Spleen Benefits in Myelofibrosis: Claire Harrison, MD